David C Hodgson, MD, MPH

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Keywords: oncology, population-based outcomes, health services research
Dr. Hodgson conducts population-based research examining the treatment and outcome of cancer patients. Ongoing studies include:
  1. Translating epidemiologic studies of radiation-related side effects into more effective and safer treatment for patients with lymphoma.
  2. Evaluating access and effectiveness of new cancer treatments and technologies in Ontario.
Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review.
J Clin Oncol. 2018 Jun 06;:JCO2017767764
Turcotte LM, Neglia JP, Reulen RC, Ronckers CM, van Leeuwen FE, Morton LM, Hodgson DC, Yasui Y, Oeffinger KC, Henderson TO
The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.
Int J Radiat Oncol Biol Phys. 2018 Apr 01;100(5):1100-1118
Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel NG, Eich HT, Illidge T, Ricardi U, Dieckmann K, Moskowitz CH, Advani R, Mauch PM, Specht L, Hoppe RT
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.
Br J Haematol. 2018 Apr 29;:
Parsons SK, Kelly MJ, Cohen JT, Castellino SM, Henderson TO, Kelly KM, Keller FG, Henzer TJ, Kumar AJ, Johnson P, Meyer RM, Radford J, Raemaekers J, Hodgson DC, Evens AM
Beyond Expert Opinion: Progress in the Development of Evidence-Based Screening Guidelines for Survivors of Childhood Cancer.
J Natl Cancer Inst. 2018 Feb 26;:
Hodgson DC, Henderson TO
Ovarian function after chemotherapy in young breast cancer survivors.
Curr Oncol. 2017 Dec;24(6):e494-e502
Morarji K, McArdle O, Hui K, Gingras-Hill G, Ahmed S, Greenblatt EM, Warner E, Sridhar S, Ali AMF, Azad A, Hodgson DC
Proton therapy in mediastinal Hodgkin lymphoma: moving from dosimetric prediction to clinical evidence.
Ann Oncol. 2017 Sep 01;28(9):2049-2050
Ricardi U, Dabaja B, Hodgson DC
Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.
J Neurooncol. 2017 Aug 19;:
Fortin D, Tsang D, Ng A, Laperriere N, Hodgson DC
Best Practice Recommendations for the Retention of Radiotherapy Records.
Clin Oncol (R Coll Radiol). 2017 Aug 12;:
Lockhart E, Bak K, Schreiner LJ, Hodgson DC, Gutierrez E, Warde P, Sharpe MB
Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer. 2017 Aug 12;:
Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, Hutchison RE
[(18) F]-FDG PET/CT in the staging and management of indolent lymphoma: A prospective multicenter PET registry study.
Cancer. 2017 Mar 13;:
Metser U, Dudebout J, Baetz T, Hodgson DC, Langer DL, MacCrostie P, Mak V, Tau N

Pages


 
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Associate Professor, Department of Radiation Oncology, University of Toronto
Staff Radiation Oncologist, Princess Margaret Cancer Centre